Cernadas JR, Brockow K, Romano A, et al. General consideration on a rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 2010; 65: 1357-66.
Campbell KL, Cohn JR, Savage MP. Clopidogrel hypersensitivity: Clinical challenges and options for management. Expert Rev Clin Pharmacol 2010; 3: 553-61.
Ghosh SK, Bandyopadhyay D. Clopidogrel-induced fixed drug eruption. J Eur Acad Dermatol Venereol 2009; 23: 1202-3.
Patrrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet active drugs: The relationships among dose, effectiveness and side effects: Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126(Suppl.): 234-64.
Khambekar SK, Kovac J, Gershlick AH. Clopidogrel induced urticarial rash in a patient with left main stem percutaneous coronary intervention: Management issues. Heart 2004; 90: 14.
Barrerira P, Cadinha S, Maleiro D, Moreira Da Silva JP. Desensitization to clopidogrel: A tailor-made protocol. Eur Ann Allergy Clin Immunol 2014; 46: 53-5.
McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-21.
Gowda RM, Misra D, Khan IA. Hypersensitivity skin rash: An adverse drug reaction to clopidogrel loading dose. Int J Cardiol 2004; 95: 333.
Doogue MP, Begg EJ, Bridgman P. Clopidogrel hypersensitivity syndrome with rash, fever and neutropenia. Mayo Clin Proc 2005; 80: 1386-70.
von Tiehl KF, Price MJ, Valencia R, et al. Clopidogrel desensitization after drug-eluting stent placement. J Am Coll Cardiol 2007; 50(21): 2039-43.
Szto GY, Linnemeier TJ, Ball MW. Fatal neutropenia and thrombocytopenia associated with ticlopidine after stenting. Am J Cardiol 1999; 83: 138-9.
Vigo PG, MacDowell AL, Wedner HJ. Successful desensitization with clopidogrel after a positive skin test. Ann Allergy Asthma Immunol 2005; 94: 132-3.
Camara MG, Alameda FQ. Clopidogrel (Plavix) desensitization: A case series. Catheter Cardiovasc Interv 2005; 65: 525-7.
Anderson J. Allergic-like reactions to drugs and other therapeutic agents: Diagnosis and treatment. Humana Press New York 2000; pp. 303-22.
Patterson R, DeSwarte RD, Greenberger PA, Grammer LC. Drug allergy and protocols for management of drug allergies. N Engl Reg Allergy Proc 1986; 7: 325-42.
Toogood J. Risk of anaphylaxis in patients receiving beta blocker drugs. J Allergy Clin Immunol 1988; 81: 1-5.
Lee-Wong M, Gadhvi D, Resnick D. Clopidogrel desensitization. Ann Allergy Asthma Immunol 2006; 96: 756-7.
Walker NE, Fasano MB, Horwitz PA. Desensitization for the management of clopidogrel hypersensitivity: Initial clinical experience. J Invasive Cardiol 2006; 18: 341-4.
Lang DM. Anaphylactoid and anaphylactic reactions; hazards of β blockers. Drug Saf 1995; 12: 299-304.
Oppedijk B, Oderkerken DA, van der Wildt JJ, Melissant CF. Rapid oral desensitization procedure in clopidogrel hypersensitivity. Neth Heart J 2008; 16: 21-3.
Owen P, Garner J, Hergott L, Page RL. Clopidogrel desensitization: Case report and review of published protocols. Pharmacotherapy 2008; 28: 259-70.
Doshi R, Enoh A, Antonopoulos P, Satter P. A novel, accelerated method of desensitization in a patient with a documented hypersensitivity reaction to clopidogrel. J Cardiol Cases 2010; 1: 158-60.
MacGlashan D Jr, Lichtenstein LM. Basic characteristics of human lung mast cell desensitization. J Immunol 1982; 139: 501-5.
Naclerio R, Mizrahi EA, Adkinson NF Jr. Immunologic observation during desensitization and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol 1983; 71: 294-301.
Sullivan TJ. Antigen-specific desensitization of patients allergic to penicillin. J Allergy Clin Immunol 1982; 69: 500-8.
Durham SR. Allergen immunotherapy (desensitization) for allergic diseases. Clin Med 2006; 6: 348-51.